Stimulation of alkaline phosphatase activity in mouse calvarial osteoblasts at 1 pM to 1 uM after 48 hrs by spectrophotometric analysis relative to nifedipine
Induction of mineralization in mouse calvarial osteoblasts assessed as increase of mineralized nodules formation after 21 days by alizarin red-S staining based spectrophotometric analysis
Induction of mineralization in mouse calvarial osteoblasts assessed as increase of mineralized nodules formation at 100 pM after 21 days by alizarin red-S staining based spectrophotometric analysis
Induction of mineralization in mouse calvarial osteoblasts assessed as increase of mineralized nodules formation measuring concentration required for maximum activity after 21 days by alizarin red-S staining based spectrophotometric analysis
Stimulation of alkaline phosphatase activity in mouse calvarial osteoblasts assessed as concentration required for maximum activity after 48 hrs by spectrophotometric analysis
Induction of new bone formation in ovariectomized BALB/c mouse model assessed as increase in bone formation rate at 10 mg/kg/day, po qd for 8 weeks by bone histomorphometry analysis (Rvb =0.10 um'3/um'2/day)
Induction of new bone formation in ovariectomized BALB/c mouse model assessed as increase in bone formation rate at 5 mg/kg/day, po qd for 8 weeks by bone histomorphometry analysis (Rvb =0.10 um'3/um'2/day)
Induction of new bone formation in ovariectomized BALB/c mouse model assessed as increase in bone formation rate at 1 mg/kg/day, po qd for 8 weeks by bone histomorphometry analysis (Rvb =0.10 um'3/um'2/day)
Induction of new bone formation in ovariectomized BALB/c mouse model assessed as increase in mineral apposition rate at 10 mg/kg/day, po qd for 8 weeks by bone histomorphometry analysis (Rvb =0.11 um/day)
Induction of new bone formation in ovariectomized BALB/c mouse model assessed as increase in mineral apposition rate at 5 mg/kg/day, po qd for 8 weeks by bone histomorphometry analysis (Rvb =0.11 um/day)
Induction of new bone formation in ovariectomized BALB/c mouse model assessed as increase in mineral apposition rate at 1 mg/kg/day, po qd for 8 weeks by bone histomorphometry analysis (Rvb =0.11 um/day)
Inhibition of osteoclastogenesis in ovariectomized BALB/c mouse model assessed as increase in OPG/RANKL ratio at 5 to 10 mg/kg/day, po qd for 8 weeks by qPCR analysis
Inhibition of osteoclastogenesis in ovariectomized BALB/c mouse model assessed as increase in OPG/RANKL ratio at 1 mg/kg/day, po qd for 8 weeks by qPCR analysis
Inhibition of osteoclastogenesis in ovariectomized BALB/c mouse model assessed as suppression of RANK gene expression at 5 to 10 mg/kg/day, po qd for 8 weeks by qPCR analysis
Inhibition of osteoclastogenesis in ovariectomized BALB/c mouse model assessed as suppression of TRAP gene expression at 5 to 10 mg/kg/day, po qd for 8 weeks by qPCR analysis
Inhibition of osteoclastogenesis in ovariectomized BALB/c mouse model assessed as suppression of RANK gene expression at 1 mg/kg/day, po qd for 8 weeks by qPCR analysis